UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms

World journal of gastroenterology : WJG, 2014-04, Vol.20 (13), p.3410-3417

2014

Volltextzugriff (PDF)

Chronic HCV infection and inflammation:Clinical impact on hepatic and extra-hepatic manifestations

World journal of hepatology, 2013-10, Vol.5 (10), p.528-540

2013

Volltextzugriff (PDF)

Chronic HCV infection is a risk factor of ischemic stroke

Atherosclerosis, 2013-11, Vol.231 (1), p.22-26

2013

Volltextzugriff (PDF)

Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data

Gastroenterology (New York, N.Y. 1943), 2006-05, Vol.130 (6), p.1636-1642

2006

Volltextzugriff (PDF)

Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease

Gastroenterology, 2004-02, Vol.126 (2), p.586-597

2004

Volltextzugriff (PDF)

Metabolic alterations and chronic hepatitis C: treatment strategies

Expert opinion on pharmacotherapy, 2011-10, Vol.12 (14), p.2215-2234

2011

Volltextzugriff (PDF)

Sonoporation by microbubbles as gene therapy approach against liver cancer

Oncotarget, 2018-08, Vol.9 (63), p.32182-32190

2018

Volltextzugriff (PDF)

Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C

Journal of hepatology, 2008-03, Vol.48 (3), p.399-406

2008

Volltextzugriff (PDF)

Hepatitis C virus clearance by direct‐acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients

Journal of gastroenterology and hepatology, 2018-07, Vol.33 (7), p.1379-1382

2018

Volltextzugriff (PDF)

Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals

JGH open, 2020-08, Vol.4 (4), p.713-721

2020

Volltextzugriff (PDF)

All-oral interferon-free treatments:The end of hepatitis C virus story,the dream and the reality

World journal of hepatology, 2015-10, Vol.7 (22), p.2363-2368

2015

Volltextzugriff (PDF)

Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration

Annals of hepatology, 2015, Vol.14 (1), p.75-82

2015

Volltextzugriff (PDF)

The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients

Saudi journal of gastroenterology, 2018-01, Vol.24 (1), p.25-29

2018

Volltextzugriff (PDF)

COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring

Frontiers in cardiovascular medicine, 2022-09, Vol.9, p.912474-912474

2022

Volltextzugriff (PDF)

Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes

Liver international, 2020-02, Vol.40 (2), p.347-354

2020

Volltextzugriff (PDF)

Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis

Atherosclerosis, 2012-04, Vol.221 (2), p.496-502

2012

Volltextzugriff (PDF)

Correlates and Prognostic Value of the First-Phase Hepatitis C Virus RNA Kinetics during Treatment

Clinical infectious diseases, 2009-08, Vol.49 (4), p.498-506

2009

Volltextzugriff (PDF)

Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antiviral therapy: A prospective study

Diabetes, obesity & metabolism, 2020-12, Vol.22 (12), p.2408-2416

2020

Volltextzugriff (PDF)

Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management

Minerva medica, 2021-04, Vol.112 (2), p.188

2021

Volltextzugriff (PDF)

TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism

Liver international, 2015-08, Vol.35 (8), p.1959-1963

2015

Volltextzugriff (PDF)

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

Hepatology (Baltimore, Md.), 2001-06, Vol.33 (6), p.1358-1364

2001

Volltextzugriff (PDF)

Early Lymphopenia and Infections in Nontraumatic Subarachnoid Hemorrhage Patients

Journal of neurosurgical anesthesiology, 2022-04, Vol.34 (2), p.243-247

2022

Volltextzugriff (PDF)

How does antiviral therapy for hepatitis B influence liver stiffness?

Future virology, 2018-08, Vol.13 (8), p.521-523

2018

Volltextzugriff (PDF)

Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress

Infection, 2018-12, Vol.46 (6), p.793-799

2018

Volltextzugriff (PDF)

The predictive value of steatosis in hepatitis C virus infection

Expert review of gastroenterology & hepatology, 2013-03, Vol.7 (3), p.205-213

2013

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(88)
Tagungsberichte
(1)

Sprache

Englisch
(87)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(67)
Humans
(54)
Male
(43)
Female
(39)
Middle Aged
(37)
Gastroenterology & Hepatology
(36)
Adult
(32)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Infectious Diseases
(25)
Aged
(23)
Hepatitis C, Chronic - Complications
(17)
Human Viral Diseases
(16)
Viral Diseases
(16)
Prevalence
(14)
Risk Factors
(14)
Viral Hepatitis
(14)
Hepatitis C, Chronic - Drug Therapy
(13)
Treatment Outcome
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms

Chronic HCV infection and inflammation:Clinical impact on hepatic and extra-hepatic manifestations

Chronic HCV infection is a risk factor of ischemic stroke

Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data

Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic disease

Metabolic alterations and chronic hepatitis C: treatment strategies

Sonoporation by microbubbles as gene therapy approach against liver cancer

Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C

Hepatitis C virus clearance by direct‐acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients

Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals

All-oral interferon-free treatments:The end of hepatitis C virus story,the dream and the reality

Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration

The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients

COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring

Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes

Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis

Correlates and Prognostic Value of the First-Phase Hepatitis C Virus RNA Kinetics during Treatment

Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antiviral therapy: A prospective study

Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management

TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

Early Lymphopenia and Infections in Nontraumatic Subarachnoid Hemorrhage Patients

How does antiviral therapy for hepatitis B influence liver stiffness?

Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress

The predictive value of steatosis in hepatitis C virus infection

Suchergebnisse filtern